Skip to main content
Clinical Trials/JPRN-UMIN000030850
JPRN-UMIN000030850
Completed
N/A

An observational study to discover novel biomarkers for nivolumab in patients with advanced gastric cancer (DELIVER trial): JACCRO GC-08 - An observational/translational study for nivolumab in gastric cancer (DELIVER trial): JACCRO GC-08

Japan Clinical Cancer Research Organization (JACCRO)0 sites501 target enrollmentJanuary 17, 2018
ConditionsGastric cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Gastric cancer
Sponsor
Japan Clinical Cancer Research Organization (JACCRO)
Enrollment
501
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 17, 2018
End Date
August 31, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Japan Clinical Cancer Research Organization (JACCRO)

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Patients previously treated with nivolumab (2\) HBs antigen\-positive or HCV antibody\-positive (3\) Patients who are regarded as inadequate for study enrollment by investigators.

Outcomes

Primary Outcomes

Not specified

Similar Trials